Sushanta K Banerjee
8PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jun 05, 2025
Targeted Nanoencapsulation of Tunicamycin Reduces Toxicity While Improving its Therapeutic Effectiveness in Pancreatic Cancer Cells.Debasmita Dutta, Sunil Upadhyay, Archana De
|Apr 30, 2024
pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model.Debasmita Dutta, Priyanka Ray, Archana De
|Mar 13, 2024
Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers.Snigdha Banerjee, Affan A Ansari, Sunil P Upadhyay
|Jun 08, 2022
The role of CCNs in controlling cellular communication in the tumor microenvironment.Lauren B Birkeness, Snigdha Banerjee, Mohiuddin Quadir
|Mar 21, 2021
CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression.Amlan Das, Inamul Haque, Priyanka Ray
|Nov 24, 2020
pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer.Priyanka Ray, Debasmita Dutta, Inamul Haque
Pageof 2
Frequent Collaborators
2 joint publications
Sanku Mallik
2 joint publications
Mohiuddin Quadir
1 joint publications
Priyanka Ray
1 joint publications
Snigdha Banerjee
1 joint publications
Affan A Ansari
1 joint publications
Sunil P Upadhyay
1 joint publications
Daniel J Mettman
1 joint publications
Debasmita Dutta
1 joint publications
Francisco J Diaz
1 joint publications
Mohiuddin Quadir
